Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Change in Accured Expenses (2016 - 2025)

Innospec's Change in Accured Expenses history spans 16 years, with the latest figure at -$2.7 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 129.67% year-over-year to -$2.7 million; the TTM value through Dec 2025 reached -$32.8 million, down 628.89%, while the annual FY2025 figure was -$32.8 million, 628.89% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$2.7 million at Innospec, down from $16.4 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $42.0 million in Q3 2024 and bottomed at -$35.9 million in Q2 2024.
  • The 5-year median for Change in Accured Expenses is $12.2 million (2022), against an average of $4.0 million.
  • The largest annual shift saw Change in Accured Expenses crashed 1573.68% in 2023 before it skyrocketed 315.38% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $31.6 million in 2021, then plummeted by 51.58% to $15.3 million in 2022, then skyrocketed by 98.04% to $30.3 million in 2023, then tumbled by 69.97% to $9.1 million in 2024, then tumbled by 129.67% to -$2.7 million in 2025.
  • Per Business Quant, the three most recent readings for IOSP's Change in Accured Expenses are -$2.7 million (Q4 2025), $16.4 million (Q3 2025), and -$19.5 million (Q2 2025).